Unicycive Therapeutics, Inc. · NASDAQ:UNCY
BlackRock, Inc. reported a 5.30% stake in Unicycive Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 30, 2026
BlackRock, Inc. reported a 5.30% stake in Unicycive Therapeutics, Inc., 1,413,381 shares, as a passive investor on Jun 30, 2026. Filed Jul 30, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 1,413,381
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.30% | 1,413,381 |
Source
Related
- Unicycive Therapeutics, Inc.
- BlackRock, Inc.
- Unicycive Therapeutics, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 8, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026